StudyCanadaStudyCanada

← All news

MUHC launches FEEL‑CUSM trial of Paxman scalp‑cooling system to reduce chemo hair loss

Source publication : 2026-11-19 · Le Canada Francais

The McGill University Health Centre is running FEEL‑CUSM to evaluate the Paxman scalp‑cooling system for chemotherapy patients. Four devices are on one‑year loan; the team aims to recruit 100 participants aged 18–40 and hopes to deliver data within a year to support public funding.

Oncologists at the Cedars Cancer Centre (MUHC) have started the FEEL‑CUSM clinical trial to assess Paxman, a scalp‑cooling device described as more affordable and user‑friendly than prior systems. The MUHC currently has four units provided on a one‑year loan by the manufacturer. The trial seeks 100 patients aged 18–40 to evaluate effects on hair preservation, patient comfort and anxiety during chemotherapy, with the objective of producing evidence to inform potential public coverage.

Read the original story · Le Canada Francais — https://www.canadafrancais.com/nouvelles-nationales/chimio-le-cusm-met-a-lessai-un-nouveau-dispositif-contre-la-perte-de-cheveux/

International students Current rules

The rules for studying in Canada.

Study permits, proof of funds, Québec requirements, work and options after graduation: explore the steps, amounts and tables in our complete guide.

Read the guide

Write to StudyCanada

Your plans or a question: let’s continue the conversation by email.

We will use these details to reply to your enquiry. Privacy